Applied DNA Sciences is a manufacturer of deoxyribonucleic acid (DNA) for supply chain security, brand protection, law enforcement or drug or biologic applications by using its polymerase chain reaction (PCR) based manufacturing platform. Under its wholly owned subsidiary, LineaRx, Inc., Co. supplies DNA for use in the in vitro medical diagnostics, preclinical biotechnology and preclinical drug and biologic development and manufacturing markets. Co. is also engaged in preclinical and animal drug candidate development directly and with collaborators focusing on therapeutically DNA constructs manufactured via its PCR-based DNA production platform. We show 24 historical shares outstanding datapoints in our coverage of APDN's shares outstanding history.
Understanding the changing numbers of APDN shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like APDN versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching APDN by allowing them to research APDN shares outstanding history
as well as any other stock in our coverage universe. |
Video: Shares Outstanding Importance
